Bio Pharma Dive
APRIL 24, 2025
The drugmaker absorbed additional tariff-related costs in the first quarter, but has taken steps to lower the financial impact it’ll have for the rest of the year and beyond.
Pharmaceutical Technology
APRIL 24, 2025
Biogen Netherlands has received marketing authorisation from the UK MHRA for its Skyclarys to treat Friedreich's ataxia.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
APRIL 24, 2025
The biotech is using AI and a trove of health data to better understand why certain conditions progress and intervene beforehand with a targeted medication.
Pharmaceutical Technology
APRIL 24, 2025
AstraZeneca, Tempus and Pathos will develop an AI-driven foundational model to develop therapeutics in oncology.
Speaker: Brian Richardson, Brian Richardson, Founder and CEO of Richardson Consulting Group
Let’s face it—most ethics and compliance trainings aren’t winning awards for engagement. But that doesn’t mean they can’t be effective, relevant, and maybe even enjoyable! Join expert Brian Richardson for a dynamic session on how to breathe new life into your ethics and compliance training programs. You’ll discover creative strategies to turn traditionally dry topics into meaningful learning experiences that resonate and drive real change.
Bio Pharma Dive
APRIL 24, 2025
Net sales of Cobenfy, whose success is imperative for Bristol Myers, totaled $27 million in the first quarter, handily beating Wall Street expectations.
Pharmaceutical Technology
APRIL 24, 2025
Repertoire Immune Medicines has signed a partnership and licence agreement with Genentech, focusing on T cell-targeted immune medicines.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
APRIL 24, 2025
Meeting patients where they are: Improving bipolar I disorder care for Black Americans Nicole.
Bio Pharma Dive
APRIL 24, 2025
The young biotech, sprung out of a Versant incubator in Switzerland, has a pair of antibody drugs it claims to have the potential to treat multiple autoimmune conditions.
pharmaphorum
APRIL 24, 2025
Roche is petitioning the US administration for an exemption from tariffs for pharmaceuticals, arguing there is no trade imbalance in its US business
Pharma Times
APRIL 24, 2025
It is hoped that the MAGIC-I study will support earlier diagnosis and personalised treatment
Advertisement
Enhancing Transparency & Efficiency Throughout the Trial Lifecycle for AI Readiness
pharmaphorum
APRIL 24, 2025
A five-year genomics study that aims to transform the care of children with cancer and improve treatment success has launched in Ireland
Pharmaceutical Commerce
APRIL 24, 2025
The deal for the San Diego hub provides the CDMO with its first-ever North American manufacturing location for prefilled syringes and cartridges.
pharmaphorum
APRIL 24, 2025
AstraZeneca has started work with Tempus and Pathos AI on a $200m project to build a comprehensive multimodal foundation model for oncology
Antidote
APRIL 24, 2025
Clinical trials are the heartbeat of medical innovationbut too often, recruitment becomes the bottleneck that stalls progress. While sponsors continue to invest millions into recruitment, 80% of clinical trials still fail to meet enrollment timelines. Why? Because the traditional strategies many rely on simply werent built for todays complex landscape.
Speaker: Amie Phillips Pablo, VP, Corporate Compliance & Privacy Officer at Novo Nordisk
In today’s complex healthcare environment, navigating third-party relationships has become even more challenging—whether it’s vendor relationships, employee activities, or patient-facing interactions. Left unmanaged, these conflicts can compromise trust, regulatory compliance, and even organizational reputation. So, how can healthcare teams stay ahead?
pharmaphorum
APRIL 24, 2025
There is currently no approved treatment for intracerebral haemorrhagic stroke, but Belgian startup Bioxodes hopes to change that
Pharmaceutical Commerce
APRIL 24, 2025
Business strategies and top news in the biotech / biopharma industry, including market access, supply chain distribution and more.
pharmaphorum
APRIL 24, 2025
Women are being overlooked in the UK's HIV response and can face barriers to accessing prevention, testing, and care, says a new campaign.
Pharmaceutical Commerce
APRIL 24, 2025
In the second part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Paul Levesque, CEO of Theratechnologies, describes potential availability challenges brought on by supply chain obstacles.
Advertisement
Download this comprehensive guide to AI and ML in the R&D Laboratory Setting.
pharmaphorum
APRIL 24, 2025
6th Gene Therapy Analytical Development Summit Europe Sara.
Pharmaceutical Technology
APRIL 24, 2025
CDMOs are crucial partners in alum-based vaccine production, managing aseptic filling with precision and efficiency.
pharmaphorum
APRIL 24, 2025
4th In Vivo Cell Engineering & Gene Editing Summit Sara.
Pharmaceutical Technology
APRIL 24, 2025
Pharmaceutical companies in Europe are requesting the EU to adopt drug pricing strategies comparable to the US.
Speaker: Simran Kaur, Co-founder & CEO at Tattva.Health
AI is transforming clinical trials—accelerating drug discovery, optimizing patient recruitment, and improving data analysis. But its impact goes far beyond research. As AI-driven innovation reshapes the clinical trial process, it’s also influencing broader healthcare trends, from personalized medicine to patient outcomes. Join this new webinar featuring Simran Kaur for an insightful discussion on what all of this means for the future of healthcare!
Drug Patent Watch
APRIL 24, 2025
"Warning: Are You About to Fall into the Generic Drug Development Trap? As a seasoned pharma professional, I've seen it time and time again: promising generic drug candidates that fail to deliver due to avoidable pitfalls. Don't let this happen to you. Check out our latest blog post to learn how to avoid the most common mistakes in generic drug development: [link] From patent strategies to regulatory hurdles, we break down the key takeaways to help you navigate the complex landscape of gene
Pharmaceutical Technology
APRIL 24, 2025
Following in the footsteps of several pharma companies, life sciences giant Thermo Fisher is doubling down on investments at its US sites.
XTalks
APRIL 24, 2025
Terumo Neuro has received premarket approval (PMA) from the FDA for its latest Carotid Stent system. The companys Carotid Stent system is indicated for the treatment of carotid artery stenosis in patients at increased risk for adverse events following a carotid endarterectomy procedure. In the press release announcing the approval, Terumo said the system is the first dual-layer micromesh carotid stent approved in the US.
Pharmaceutical Technology
APRIL 24, 2025
MSD is also bracing for a $200m hit due to tariffs as it accelerates US manufacturing and shifts its global supply strategy.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
XTalks
APRIL 24, 2025
BD (Becton, Dickinson and Company) announced the FDA 510(k) clearance and commercial launch of its Phasix ST Umbilical Hernia Patch this week. BD says the device is the first fully bioabsorbable hernia mesh specifically designed for umbilical hernia repair. The Phasix ST Umbilical Hernia Patch offers a unique absorbable solution for umbilical hernia repair, the company said.
Pharma Marketing Network
APRIL 24, 2025
Introduction Artificial Intelligence (AI) is no longer just a futuristic concept in pharmaceutical marketingits the present and future. In 2025, AI-powered pharma marketing is transforming how companies engage healthcare professionals (HCPs), patients, and stakeholders. With evolving compliance requirements and rising demand for personalization, pharma marketers are adopting intelligent platforms to stay ahead.
XTalks
APRIL 24, 2025
Its official the US food supply may see more natural alternatives to synthetic dyes. The US Department of Health and Human Services (HHS) and the FDA have announced a plan to phase out petroleum-derived synthetic food dyes from the US food supply by the end of 2026. The effort targets six commonly used FD&C (Federal Food, Drug and Cosmetic) dyes, including Red No. 40 and Yellow No. 5.
Drug Discovery World podcast
APRIL 24, 2025
This is the latest episode of the free DDW narrated podcast, titled Where are scientists making waves in drug discovery?, which covers three articles written for DDW Volume 24 Issue 3, Summer 2023. They are called: How pharma is targeting advances in Alzheimers treatments , The start-up disrupting the field of womens reproductive health and India: Why is the country ramping up drug discovery research?
Expert insights. Personalized for you.
252 
Let's personalize your content